Retatrutide 10mg - Image 1
Click to enlarge
Henectus tincidunt
Henectus tincidunt $429.00
Back to products
Eames lounge chair
Eames lounge chair $399.00

Retatrutide 10mg

$80.00

Triple Receptor Agonist — Most Effective for Fat Loss (24% Weight Reduction in Clinical Trials)

Compare
Add to wishlist
Category:
Description

Source manufacturer

Direct LPPEPTIDE production and fulfillment.

Batch traceable

Batch ID and test date stay connected.

Securely packed

Packed for stable transit from our fulfillment flow.

AttributeDetails
ProductLPPEPTIDE RT10
Knowledge SourceRetatrutide (RT)
Specification10 mg × 10 vials per box
CategoryWeight Loss & Metabolic
Research FocusWeight Loss & Metabolic
FormLyophilized Powder
ReconstitutionLPPEPTIDE knowledge source: Add 1.0 mL bacteriostatic water to achieve an approximate concentration of 5.0 mg/mL. Reference range is 2–8 mg once weekly with gradual dose escalation over 8–12 weeks. At 5.0 mg/mL, 1 unit (U) on a U-100 insulin syringe is approximately 50 mcg.
Storage (Lyophilized)Store at -20°C (-4°F) or below in a dry, dark environment.
Storage (Reconstituted)Store at 2–8°C (36–46°F). Protect from light and use within approximately 4 weeks. Allow the sealed vial to reach room temperature before opening to minimize condensation.
Overview
Research
Dosing & Protocol
Side Effects
COA & Testing
Q&A - 124
About Lppeptide

What is RT10?

Triple-receptor incretin agonist profile for metabolic research. The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Retatrutide 10mg is mapped to Lppeptide SKU RT10. Current storefront values use our product data: 10mg x 10 vials /box, $80.00 USD per box. Lppeptide reference specs: 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials.

Research context

The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Research typically centers on GLP-1, GIP, and glucagon receptor signaling, with endpoints such as appetite signaling, glucose handling, and energy balance models.

Commonly matched with

RT10 is commonly reviewed alongside RT20, RT30, TR10, TR20, Tirzepatide. Keep each combination tied to a defined research objective and lot record.

Compliance notice

RT10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Research typically centers on GLP-1, GIP, and glucagon receptor signaling, with endpoints such as appetite signaling, glucose handling, and energy balance models.

Study design notes

Use the Lppeptide product knowledge record, current Lppeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched Lppeptide reference specification is 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials.

Dosing & Protocol

Lppeptide handling reference

LPPEPTIDE knowledge source: add 1.0 mL bacteriostatic water for about 5.0 mg/mL. Reference range is once weekly 2-8 mg with gradual 8-12 week escalation. At 5.0 mg/mL, 1 U on a U-100 syringe is about 50 mcg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

Retatrutide 10mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 1.0 mL bacteriostatic water for about 5.0 mg/mL. Reference range is once weekly 2-8 mg with gradual 8-12 week escalation. At 5.0 mg/mL, 1 U on a U-100 syringe is about 50 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C or below, dry and dark. Reconstituted: 2-8 deg C, protect from light, use within about 4 weeks, and let the sealed vial reach room temperature before opening to reduce condensation.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Published discussion commonly focuses on gastrointestinal tolerance, hydration status, appetite-pathway effects, and limited long-term human safety data.

Contraindications

Do not use RT10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Use extra caution in models involving other incretin, glucose-lowering, appetite, or gastric-emptying pathways.

COA & Testing

Certificate of Analysis

Each Lppeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps RT10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: RT10
  • Product: Retatrutide 10mg
  • Storefront specification: 10mg x 10 vials /box
  • Lppeptide reference specs: 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials
  • Listed box price: $80.00 USD
  • Reference: Lppeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
Q&A • 124

Q: Is RT10 sold for research use only?

A: RT10 is supplied by Lppeptide for qualified research use only. It is not for human or veterinary use, not for consumption, and local rules may vary by jurisdiction.

Q: Where do I confirm the current RT10 lot documentation?

A: Use the COA & Testing tab, product label, and current Lppeptide batch record to confirm SKU RT10, specification, identity, and handling details before research use.

Q: Can RT10 be reviewed with related products?

A: Yes, when the study protocol defines the rationale. Common comparison or stack candidates include RT20, RT30, TR10, TR20. Keep fixed-ratio blends and single-compound materials documented separately.

Q: Why can details differ from reference articles or catalog pages?

A: Reference pages provide general compound context. Lppeptide product pages should follow the current product record, active COA, lot-specific handling sheet, and lab SOP.

About Lppeptide

Direct catalog supply

Lppeptide product pages use our own SKU, package, price, and stock data first. Lppeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

Q&A • 124

Q: Is RT10 sold for research use only?

A: RT10 is supplied by Lppeptide for qualified research use only. It is not for human or veterinary use, not for consumption, and local rules may vary by jurisdiction.

Q: Where do I confirm the current RT10 lot documentation?

A: Use the COA & Testing tab, product label, and current Lppeptide batch record to confirm SKU RT10, specification, identity, and handling details before research use.

Q: Can RT10 be reviewed with related products?

A: Yes, when the study protocol defines the rationale. Common comparison or stack candidates include RT20, RT30, TR10, TR20. Keep fixed-ratio blends and single-compound materials documented separately.

Q: Why can details differ from reference articles or catalog pages?

A: Reference pages provide general compound context. Lppeptide product pages should follow the current product record, active COA, lot-specific handling sheet, and lab SOP.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 10mg”

Your email address will not be published. Required fields are marked *

Shipping and Delivery
wd-ship-1
wd-ship-2

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.